Article Sidebar
Published:
Jan 11, 2024Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Hypoglycemic and glucose lowering properties of Cordyceps militaris
Abstract
Diabetes mellitus is a serious endocrine disease characterized by hyperglycemia. This disease has been regarded as a major global health issue. Although majority of the current therapeutic approaches are beneficial in treating diabetes, there are still unfavorable side effects. The Chinese traditional medicinal fungi, Cordyceps militaris, has been used in the treatment of diabetes mellitus for centuries. This study summarizes the chemical compounds in Cordyceps militaris and their corresponding hypoglycemic effect in the development of therapeutic agents for diabetes mellitus based on recent reports. Several studies using chemically induced diabetic rats and mice models have established the antidiabetic effect of Cordyceps militaris administered at various doses. This report reveals that Cordyceps militaris has a great deal of promise and should be taken into consideration for the development of novel antidiabetic therapies.
